Maximum quantity allowed is 999
Please select the quantity
CAS RN: 1744-22-5 | Product Number: A2423
Riluzole
Purity: >98.0%(T)(HPLC)
Synonyms:
- 2-Amino-6-(trifluoromethoxy)benzothiazole
Documents:
Size | Unit Price | Belgium | Japan* | Quantity |
---|---|---|---|---|
5G |
£35.00
|
3 | ≥40 |
|
25G |
£121.00
|
1 | 19 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Specifications
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Melting point | 116.0 to 120.0 °C |
Properties (reference)
Melting Point | 118 °C |
Solubility in water | Insoluble |
Solubility (soluble in) | Methanol,Ether,Dimethylformamide,Acetone |
GHS
Pictogram |
![]() |
Signal Word | Danger |
Hazard Statements | H300 : Fatal if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
Related Laws:
RTECS# | DL2830000 |
Transport Information:
UN Number | UN2811 |
Class | 6.1 |
Packing Group | II |
HS Number | 2934208090 |
Application
Riluzole: A Neuroprotective Agent
Riluzole is a neuroprotective agent that blocks glutamatergic neurotransmission in the neuronal synapse. Riluzole would affect neurons by 3 mechanisms: by inhibiting excitatory L-glutamic acid [G0059] release, inhibiting events following stimulation of excitatory glutamic acid receptors and stabilizing the inactivated state of voltage-dependent sodium channels. Riluzole is mainly used for the treatment of amyotrophic lateral sclerosis (ALS) which would be associated with glutamate excitotoxicity. (The product is for research purpose only.)
References
- The pharmacology and mechanism of action of riluzole
- Riluzole: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis
- Riluzole Series. Synthesis and in Vivo "Antiglutamate" Activity of 6-Substituted-2-benzothiazolamines and 3-Substituted-2-imino-benzothiazolines
- Riluzole, neuroprotection and amyotrophic lateral sclerosis (a review)
- A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number
Incorrect Lot Number is entered
The requested analytical chart is not available. Sorry for the inconvenience.